Zobrazeno 1 - 6
of 6
pro vyhledávání: '"T.P. Sijmonsma"'
Autor:
A.J.H.H.M. van Oostrom, T.P. Sijmonsma, C. Verseyden, E.H.J.M. Jansen, E.J.P. de Koning, T.J. Rabelink, M. Castro Cabezas
Publikováno v:
Journal of Lipid Research, Vol 44, Iss 3, Pp 576-583 (2003)
Atherosclerosis is a low-grade inflammatory disease involving leukocytes, lipids, and glucose leading to endothelial dysfunction. Since activation of neutrophils by triglycerides and glucose has been described in vitro, we hypothesized that the postp
Externí odkaz:
https://doaj.org/article/efa54979d97243b9a272744841e0348a
Autor:
A.J.H.H.M. van Oostrom, H.W.M. Plokker, T.P. Sijmonsma, Ton J. Rabelink, P.P.Th. de Jaegere, C. Verseyden, M. Castro Cabezas
Publikováno v:
Atherosclerosis. 177:175-182
Activation of leukocytes is obligatory for inflammation and atherogenesis by adhering to the endothelium via specific ligands. Although in vitro studies have shown that triglycerides (TG) can activate leukocytes, it is unknown whether this occurs in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c7d15f23665f18fbe1249a770d85108
https://doi.org/10.1016/j.atherosclerosis.2004.07.004
https://doi.org/10.1016/j.atherosclerosis.2004.07.004
Publikováno v:
Metabolism: clinical and experimental. 52(2)
Atherosclerosis is an inflammatory disorder involving leukocytes and lipids. To study the relationship between leukocytes and lipids in vivo, leukocyte changes were determined in 14 healthy males (age, 23 ± 3 years; body mass index [BMI], 21.9 ± 1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::935a5bc60f854c151e50155fa97e729e
https://pubmed.ncbi.nlm.nih.gov/12601632
https://pubmed.ncbi.nlm.nih.gov/12601632
Autor:
A. Alipour, C. Verseyden, Geesje M. Dallinga-Thie, M. Castro Cabezas, A.J.H.H.M. van Oostrom, T.P. Sijmonsma, H.W.M. Plokker
Publikováno v:
Atherosclerosis Supplements. 8:207
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::181194ab7e6400dd271f49680174cf03
https://doi.org/10.1016/s1567-5688(07)71788-9
https://doi.org/10.1016/s1567-5688(07)71788-9
Autor:
H.W.M. Plokker, A. Alipour, Ton J. Rabelink, M. Castro Cabezas, P. De Jaegere, T.P. Sijmonsma, A.J.H.H.M. van Oostrom
Publikováno v:
Atherosclerosis Supplements. 5:72
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5416928e9ba5e2a9c416acb3b6f028d9
https://doi.org/10.1016/s1567-5688(04)90310-3
https://doi.org/10.1016/s1567-5688(04)90310-3
Publikováno v:
Atherosclerosis Supplements. 2:37
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::479893f84035121317c340dbb215e063
https://doi.org/10.1016/s1567-5688(01)80025-8
https://doi.org/10.1016/s1567-5688(01)80025-8